Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
High-cost weight loss drugs are sending employers to nutrition counseling in a boost for startups
Tags Health care industry Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Medicare can now cover Eli Lilly’s Zepbound for sleep apnea, CMS says
Tags US: News LILLY DRN Business
From CNBC.com News
Cramer's Lightning Round: 'I'd be careful' with Novo Nordisk
Tags stocks Business News Lemonade Inc
From CNBC.com News
Digital health companies got pummeled by Wall Street in 2024 as industry adapts to post-Covid slowdown
Tags AI / Artificial Intelligence Doximity Inc Oscar Health Inc
From CNBC.com News
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Pharmaceuticals
From CNBC.com News
CNBC Daily Open: With cooler-than-expected PCE, would the Fed’s dot plot have looked different?
Tags Novo Nordisk A/S Daily Open Inflation
From CNBC.com News
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.
Tags Business News Health care industry Novo Nordisk A/S
From CNBC.com News
Novo Nordisk shares plunge 22% after CagriSema obesity drug trial results
Tags Breaking News: Europe Biotechnology Biotech and Pharmaceuticals
From CNBC.com News
Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
Tags Health care industry Pfizer Inc AstraZeneca PLC
From CNBC.com News
Europe's economy faces a bumpy ride in 2025. Here are 5 things to watch
Tags Economy Novo Nordisk A/S BE Semiconductor Industries NV
From CNBC.com News
Healthy Returns: Novo Nordisk's Ozempic faces scrutiny over potential link to rare eye condition
Tags Healthy Returns Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: A huge deal to boost Novo Nordisk's manufacturing is one step closer to closing
Tags LILLY DRN Health & Science Social issues
From CNBC.com News
Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly
Tags Health care industry Companies Novo Nordisk A/S
From CNBC.com News
The weight-loss drug boom has become one of the internet's biggest scams
Tags LILLY DRN Cybersecurity Social media
From CNBC.com News
Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data
Tags Amgen Inc GE HealthCare Technologies Inc Social issues
From CNBC.com News
Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
Tags Health care industry Social issues Companies
From CNBC.com News
Hiccups in ETFs tracking MicroStrategy occurring as bull market fuels trading boom in single-stock funds
Tags Breaking News: Markets Microstrategy Inc Novo Nordisk A/S
From CNBC.com News
Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial
Tags Business News Biotech and Pharmaceuticals Pharmaceuticals
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags LILLY DRN Investing Best Buy Co Inc
From CNBC.com News
Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau
Tags Biotechnology Business Health & Science
From CNBC.com News
Amgen stock falls as analysts mull over weight loss drug’s bone density data
Tags Business News Pharmaceuticals Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
Tags Viking Therapeutics Inc Health & Science Social issues
From CNBC.com News
Healthy Returns: Wegovy may reduce knee pain in patients with a type of arthritis and obesity
Tags Social issues Health & Science Science
From CNBC.com News
Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says
Tags US: News LILLY DRN Business
From CNBC.com News
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
Tags Pharmaceuticals Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Ozempic And Wegovy Maker Novo Nordisk Asks FDA To Halt Production Of Compounded Fat Loss Drugs Due To Their 'Inherent Complexity'
Tickers HIMS LLY NEWS NVO
Tags LLY News Food and Drug Administration
From Benzinga
Healthy Returns: Weight loss, diabetes drugs may reduce alcohol and opioid use
Tags Science LILLY DRN Social issues
From CNBC.com News
Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies
Tags US: News LILLY DRN Biotechnology
From CNBC.com News
Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034
Tags Health care industry Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Cramer's Lightning Round: Uranium Energy is 'the real deal'
Tags Mad Money Markets Investment strategy
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.